News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rojkjaer Lisa
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/17/2023 |
4
| Rojkjaer Lisa (Chief Medical Officer) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.65, valued at
$247.5k
|
|
| 02/28/2023 |
4
| Rojkjaer Lisa (Chief Medical Officer) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Sold 2,156 shares
@ $1.6812, valued at
$3.6k
Exercised 4,127 restricted stock units
@ $0 |
|
| 11/29/2022 |
4
| Rojkjaer Lisa (Chief Medical Officer) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Sold 2,116 shares
@ $2.7193, valued at
$5.8k
Exercised 4,127 restricted stock units
@ $0 |
|
| 08/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/29/2021 |
4
| Rojkjaer Lisa (Chief Medical Officer) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Sold 1,950 shares
@ $4.8006, valued at
$9.4k
Sold 2,591 shares
@ $4.8191, valued at
$12.5k
Exercised 8,254 restricted stock units
@ $0 |
|
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2021 |
3
| Rojkjaer Lisa (Chief Medical Officer) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
|
|